重药控股：上半年归母净利润2.82亿元 同比增长18.56%

Core Viewpoint - The company reported a revenue of 41.188 billion yuan for the first half of the year, reflecting a year-on-year growth of 3.54% [2] - The net profit attributable to shareholders reached 282 million yuan, marking an 18.56% increase compared to the previous year [2] - The basic earnings per share stood at 0.16 yuan [2] Financial Performance - Revenue for the first half of the year: 41.188 billion yuan, up 3.54% year-on-year [2] - Net profit attributable to shareholders: 282 million yuan, up 18.56% year-on-year [2] - Basic earnings per share: 0.16 yuan [2]